Kyowa Kirin North America is a dynamic specialty pharmaceutical company harnessing advanced biotechnologies to create and deliver innovative medicines in areas like bone and mineral health, hematology, oncology, and rare diseases. We focus on developing therapies for conditions that lack adequate treatments, taking projects from initial drug discovery through to commercial launch.
